Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (558kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-535783
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.53578
Zusammenfassung
Background: Type 2 Diabetes (DM2) and the consecutively daily use of antidiabetic medication are characterized by a frequent prevalence worldwide and were shown to impact the initiation and progression of malignant diseases. While these effects were observed in a variety of malignancies, comprehensive data about the role of DM2 and antidiabetic drugs in the outcome of head and neck melanoma (HNM) ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags